Guidelines for the management of drug-induced hypersensitivity syndrome 2023. Mizukawa Y, Hama N, Niihara H, Miyagawa F, et al. J Dermatol 2025 Feb 3. doi: 10.1111/1346-8138.17609.

Read + Share

Amedeo Smart

Independent Medical Education

Mizukawa Y, Hama N, Niihara H, Miyagawa F, et al. Guidelines for the management of drug-induced hypersensitivity syndrome 2023. J Dermatol 2025 Feb 3. doi: 10.1111/1346-8138.17609.
PMID: 39895539